Hydroxychloroquine Drugs Market Opportunity Assessment and Forecast up to 2027
Hydroxychloroquine Drugs Market is gaining increased attention in the current times owing to results from a French Study that states these are effective in treating Coronavirus infection, plaguing the planet.
Hydroxychloroquine Drugs Market is gaining increased attention in the current times owing to results from a French Study that states these are effective in treating Coronavirus infection, plaguing the planet.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
India, a major producer and exporter of hydroxychloroquine is ramping up
production to meet increased demand from a number of other countries, including
the United States of America, to which it is giving away about 3 million tablets of
the drug, and nine metric tons of API – Active Pharmaceutical Ingredient.
Some of the leading Indian manufacturers in the market landscape are Intas
Pharmaceuticals, McW Healthcare of Indore, Macleods Pharmaceuticals, and
Cipla.
Some of the prominent players operating in the global hydroxychloroquine drugs
market are the following - Novartis International AG, Sanofi S.A., Amneal
Pharmaceuticals, Inc., Laurus Labs Ltd., Prasco Laboratories, Cardinal Health,
Concordia Pharmaceuticals Inc.
©2019 Transparency Market Research, All Rights Reserved
Change language